GR# | Feature(s) or putative feature(s) a | Cdubdub | Cdublac | Cdublau | Cmuy | Ctur | Cuni | Cmal | Csak | Shared locus |
---|---|---|---|---|---|---|---|---|---|---|
1 | Acyl reductase-transketolase | - | + | + | + | + | + | + | + | Â |
2 | Taurine metabolism | - | + | + | + | + | + | + | + | Â |
3 | Environmental persistence capsule, yih | - | + | + | + | + | + | + | + | Â |
4 | Filamentous hemagglutinin outer membrane protein | + | + | + | - | + | + | + | + | Â |
5 | ybh transporter, putative antibiotic resistance efflux pump | + | + | + | - | + | + | + | + | Â |
6 | γ4 fimbriae | + | + | + | - | + | + | + | + |  |
7 | Phospho-alpha-glucosidase (α-methyl D-glucoside) | + | + | + | - | + | + | + | + |  |
8 | DMSO, urea (urt), biotin utilization, MAR (4-aminobutyrate) | + | + | + | + | + | - | + | + | Â |
9 | π fimbriae | + | + | + | + | + | + | + | - |  |
10 | Hydrolase | + | + | + | + | + | + | + | - | Â |
11 | Transporter and Rhodanese-related sulfurtransferases | + | + | + | + | + | + | + | - | l |
12 | Lysozyme, virulence regulator | + | + | + | + | + | + | + | - | Â |
13 | LPS/core OS 2 gene pair | + | + | + | + | + | + | + | - | Â |
14 | MFS transporter, regulator and dehydrogenase | + | - | - | + | + | + | + | + | f |
15 | Membrane hydrolase | + | + | - | + | - | + | + | + | Â |
16 | Large repetitive hemolysin | + | + | - | + | + | + | + | - | Â |
17 | Putative ABC transporter and DMT permease | + | + | + | - | + | + | + | - | d |
18 | Beta-glucosidase | + | + | + | + | - | - | + | + | Â |
19 | Hypothetical proteins | + | + | + | + | - | + | + | - | Â |
20 | Fatty acid desaturase | + | + | + | + | + | - | - | + | Â |
21 | OM autotransporter barrel | + | + | + | + | + | + | - | - | a |
22 | NO reductase | + | + | + | + | + | + | - | - | Â |
23 | Oxidoreductase | + | + | + | + | + | + | - | - | Â |
24 | Spermidine-preferential uptake system | + | + | + | + | + | + | - | - | Â |
25 | Glucuronyl hydrolase, sucrose permease | + | + | + | + | + | + | - | - | Â |
26 | Hypothetical proteins | + | + | + | - | + | + | - | - | Â |
27 | Hypothetical proteins | + | - | + | - | + | + | + | - | Â |
28 | CRISPR | + | + | - | - | + | - | + | + | Â |
29 | Inositol | + | + | - | + | + | + | - | - | Â |
30 | Non-heme chloroperoxidase, MxcK | - | - | - | + | + | + | + | + | g |
31 | Acetyltransferase | - | - | - | + | + | + | + | + | Â |
32 | Hypothetical proteins | - | + | + | + | - | + | + | - | Â |
33 | Putative membrane protein and regulator | + | + | + | + | - | + | - | - | h |
34 | Malonate | + | - | - | + | + | + | + | - | Â |
35 | Formate dehydrogenase | + | - | - | - | + | + | + | + | Â |
36 | Phenolic sulfur ester | + | + | + | + | - | - | - | - | Â |
37 | Deoxyguanosinetriphosphate triphosphohydrolase | + | + | + | + | - | - | - | - | Â |
38 | Ferrichrome iron receptor | + | + | + | + | - | - | - | - | Â |
39 | Putative membrane and hypothetical proteins | + | + | + | + | - | - | - | - | i |
40 | Arylsulfatase | + | + | + | + | - | - | - | - | j |
41 | Redundant methionine transporter | + | + | + | + | - | - | - | - | Â |
42 | Ethanolamine permease and deaminase | + | + | + | + | - | - | - | - | Â |
43 | Ferrichrome-iron receptor | + | + | + | + | - | - | - | - | Â |
44 | Hypothetical proteins | + | + | + | + | - | - | - | - | Â |
45 | Ornithine monooxygenase, BtrH | + | + | + | + | - | - | - | - | Â |
46 | Transmembrane tRNA/peptide synthetase | + | + | + | + | - | - | - | - | Â |
47 | Indole | + | + | + | + | - | - | - | - | Â |
48 | Putative LPS modification operon | - | - | - | - | + | + | + | + | i |
49 | Toxin-antitoxin pair | - | - | - | - | + | + | + | + | Â |
50 | Exported protein | - | - | - | - | + | + | + | + | Â |
51 | CynX | + | + | + | - | - | - | + | - | Â |
52 | γ4 fimbriae | + | + | + | - | + | - | - | - | l |
53 | Acyl enzymes | + | + | + | - | + | - | - | - | Â |
54 | Membrane protein | - | + | + | - | + | - | - | + | Â |
55 | Curli | + | - | - | - | + | + | + | - | Â |
56 | Methyl-accepting chemotaxis and/or hypothetical protein | + | + | - | - | + | + | - | - | n |
57 | Macrophage infectivity potentiator-related protein and regulator | - | - | - | + | + | - | + | + | Â |
58 | Putative monooxygenase and transcriptional regulators | + | + | + | - | - | - | - | - | d |
59 | Oligopeptide transport system | + | + | + | - | - | - | - | - | Â |
60 | Hypothetical proteins | + | + | + | - | - | - | - | - | Â |
61 | Methyl-accepting chemotaxis and/or hypothetical proteins | + | + | + | - | - | - | - | - | Â |
62 | Beta-lactamase | - | - | - | - | - | + | + | + | j |
63 | Peptide chain release factor | - | - | - | - | + | + | + | - | Â |
64 | Chemotaxis | - | - | - | + | - | + | + | - | e |
65 | Helicase | - | + | + | + | - | - | - | - | Â |
66 | Hypothetical proteins | - | - | + | - | - | + | - | + | Â |
67 | Dulcitol | - | - | - | + | + | + | - | - | Â |
68 | Short-chain dehydrogenase and regulator | + | - | + | - | - | - | - | - | d |
69 | Type I RMS | - | + | + | - | - | - | - | - | c |
70 | Pyroxidine/pyroxidal metabolism | - | + | + | - | - | - | - | - | e |
71 | qseBC, ompV | - | + | + | - | - | - | - | - | f |
72 | Maltose phosphate PTS and glucosidase | - | + | - | + | - | - | - | - | Â |
73 | Cellulose degradation | - | + | - | + | - | - | - | - | Â |
74 | Transporter and secreted pair | - | - | - | + | - | - | - | + | Â |
75 | Hypothetical proteins | - | - | - | + | - | - | - | + | Â |
76 | β fimbriae | - | + | - | - | - | - | - | + |  |
77 | Periplasmic or lipo-protein | - | - | - | - | + | - | - | + | Â |
78 | α-mannosidase | - | - | - | - | + | - | - | + |  |
79 | Regulator and hypothetical protein | - | - | - | - | + | + | - | - | Â |
80 | Short chain dehydrogenase | - | - | - | - | + | + | - | - | Â |
81 | Membrane protein | - | - | - | - | - | - | + | + | Â |
82 | γ1 fimbriae | - | - | - | - | - | - | + | + |  |
83 | (+/−) putative membrane and (+/−) hypothetical proteins; variable | + | + | + | + | - | + | + | - |  |
84 | Arsenic resistance; MFS transporter, regulator and hypothetical proteins | + | - | - | - | - | - | - | - | i |
85 | Putative monoamine oxidase, carboxymuconolactone decarboxylase and hypothetical proteins | + | - | - | - | - | - | - | - | l |
86 | Hypothetical proteins | - | + | - | - | - | - | - | - | Â |
87 | Putative monoamine oxidase, carboxymuconolactone decarboxylase and hypotheticals; homologous to GR85 | - | + | - | - | - | - | - | - | i |
88 | Putative sulfatase and hypothetical proteins | - | - | + | - | - | - | - | - | a |
89 | LysE Superfamily exporter | - | - | + | - | - | - | - | - | d |
90 | Hypothetical proteins | - | - | + | - | - | - | - | - | Â |
91 | Radical SAM and ABC ATPase proteins | - | - | + | - | - | - | - | - | Â |
92 | Mannanase | - | - | + | - | - | - | - | - | g |
93 | Putative reductases and hypothetical proteins | - | - | + | - | - | - | - | - | i |
94 | Membrane protein | - | - | + | - | - | - | - | - | k |
95 | D-glucarate permease, transketolase, homologous to GR117 | - | - | - | + | - | - | - | - | c |
96 | Type I RMS | - | - | - | + | - | - | - | - | d |
97 | Modulator of drug activity B (mdaB), MFS transporter and regulator | - | - | - | + | - | - | - | - | n |
98 | Hypothetical proteins | - | - | - | + | - | - | - | - | Â |
99 | Hypothetical proteins | - | - | - | + | - | - | - | - | h |
100 | Hypothetical proteins | - | - | - | + | - | - | - | - | Â |
101 | FHA | - | - | - | + | - | - | - | - | Â |
102 | L-rhamnose ABC transporter | - | - | - | + | - | - | - | - | Â |
103 | Urea carboxylase | - | - | - | + | - | - | - | - | Â |
104 | Heteropolysaccharide degradation | - | - | - | - | + | - | - | - | b |
105 | qseBC, ompV | - | - | - | - | + | - | - | - | d |
106 | Sigma factor, catalase | - | - | - | - | + | - | - | - | k |
107 | Beta-glucosidase, cellobiose | - | - | - | - | + | - | - | - | Â |
108 | Short chain dehydrogenase | - | - | - | - | + | - | - | - | Â |
109 | Paralogous enzyme island | - | - | - | - | + | - | - | - | Â |
110 | DND operon | - | - | - | - | + | - | - | - | Â |
111 | Xanthosine utilization | - | - | - | - | + | - | - | - | Â |
112 | κ fimbriae | - | - | - | - | - | + | - | - |  |
113 | Putative epoxide hydrolase | - | - | - | - | - | + | - | - | b |
114 | Cupin superfamily homologues | - | - | - | - | - | + | - | - | d |
115 | Hypothetical proteins | - | - | - | - | - | + | - | - | Â |
116 | Hypothetical proteins | - | - | - | - | - | + | - | - | i |
117 | D-glucarate permease, transketolase | - | - | - | - | - | + | - | - | Â |
118 | Large exoproteins involved in heme utilization or adhesion | - | - | - | - | + | - | + | + | Â |
119 | MipA homologue and signal transduction pair | - | - | - | - | - | - | + | - | i |
120 | Hemolysin, activator and secretion | + | - | + | - | - | - | - | - | Â |
121 | Membrane spanning and hypothetical proteins | - | - | - | - | - | - | - | + | a |
122 | Hypothetical proteins | - | - | - | - | - | - | - | + | Â |
123 | Csak invasin locus | - | - | - | - | - | - | - | + | Â |
124 | Unique transporter | - | - | - | - | - | - | - | + | e |
125 | Nucleoside-sugar efflux | - | - | - | - | - | - | - | + | Â |
126 | γ1 fimbriae | - | - | - | - | - | - | - | + |  |
127 | nanC, sugar isomerase, hydrolase | - | - | - | - | - | - | - | + | Â |
128 | Paralogous enzyme island | - | - | - | - | - | - | - | + | Â |
129 | Sialic acid | - | - | - | - | - | - | - | + | Â |